NUSAP1 and glioblastoma: These results provide strong evidence suggesting that LINC01393 promotes NUSAP1 expression by inhibiting miR-128-3p and LINC01393/miR-128-3p/NUSAP1 axis may significantly contribute to progression of GBM.